Global Psoriatic Arthritis Market Scrutinised in Infiniti Research Report Available at MarketPublishers.com
06 Jan 2016 • by Natalie Aster
LONDON – The global psoriatic arthritis is set to show moderate growth over the next few years, with its growth encouraged by such factors as recent launch of new products, an increase in biologic therapies’ penetration, and more. Its CAGR is expected to be no more than 5 percent through 2019.
Growth in patient population and unmet medical needs are some other important factors driving the market growth.
Increasing costs of biologics, adverse effects of drugs and the use of CAM by patients are amid main market challenges.
South America and North America are forecast to dominate the global marketplace. Their combined market share is expected to be over 40 percent by early 2019.
Key vendors in this marketplace comprise: AbbVie, UCB, Celgene, etc.
Cutting-edge research study “Global Psoriatic Arthritis Market 2015-2019” drawn up by Infiniti Research offers a thorough discussion of the global market for psoriatic arthritis. The report provides an in-depth overview of the disease and contains a detailed pipeline portfolio. It sheds light on novel mechanisms being targeted by pipeline candidates. The study estimates market sizing and includes a five forces analysis. The research report investigates market segments and outlines performance of regional markets. It explores market drivers, delves deep into market challenges and examines the vendor landscape. The study forecasts market development trends and contains company profiles.
Global Psoriatic Arthritis Market 2015-2019
Published: December, 2015
Price: US$ 3,000.00
More in-demand reports by the publisher are available at Infiniti Research page.